Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With <i>BRCA</i>-Mutated and/or BRCAness Phenotype: A Randomized Phase III TrialDomenica Lorusso, Giovanni Scambia, Dominique Ronzulli et al.|Journal of Clinical Oncology|2024Cited by 3